EQUITY FINANCING AGREEMENTEquity Financing Agreement • March 20th, 2024 • Bubblr Inc. • Services-computer programming, data processing, etc.
This EQUITY FINANCING AGREEMENT (the “Agreement”), dated as of March 9, 2022 (the “Execution Date”), is entered into by and between Bubblr, Inc., a Wyoming corporation with its principal executive office at 21 West 46th Street, New York, NY 10036 (the “Company”), and GHS Investments LLC, a Nevada limited liability company, with offices at 420 Jericho Turnpike, Suite 102, Jericho, NY 11753 (the “Investor”).
EQUITY FINANCING AGREEMENTEquity Financing Agreement • May 3rd, 2024 • Yuenglings Ice Cream Corp • Services-business services, nec
This EQUITY FINANCING AGREEMENT (the “Agreement”), dated as of January 8, 2024 (the “Execution Date”), is entered into by and between Yuengling’s Ice Cream Corporation, a Nevada corporation (the “Company”), and Trillium Partners, LP, a Delaware limited partnership (the “Investor”).
EX-10.8 5 cp_ex10z8.htm DRAWDOWN EQUITY FINANCING AGREEMENT AMENDMENT NO. 1 to DRAWDOWN EQUITY FINANCING AGREEMENTEquity Financing Agreement • May 5th, 2020 • Massachusetts
THIS AGREEMENT dated as of the day of May 14, 2010 (the “Agreement”) between Auctus Private Equity Fund, LLC a Massachusetts corporation (the “Investor”), and Capital Reserve Canada, Ltd. a corporation organized and existing under the laws of the Province of Alberta (the “Company”).
AMENDMENT TO EQUITY FINANCING AGREEMENTEquity Financing Agreement • September 9th, 2019 • DSG Global Inc. • Services-computer integrated systems design
THIS AMENDMENT TO EQUITY FINANCING AGREEMENT (the Amendment”) is entered into on April 19, 2019 by and between DSG Global, Inc., a Nevada corporation (“DSGT”) and GHS Investments, LLC, a Nevada limited liability company (“GHS). Each party to this Amendment is referred to herein as a “Party,” and collectively as the “Parties.”
AMENDMENT No. 1 TO EQUITY FINANCING AGREEMENTEquity Financing Agreement • June 3rd, 2022 • DarkPulse, Inc. • Services-prepackaged software
This Amendment No. 1 (this “Amendment”) to the Equity Financing Agreement dated May 27, 2022 (the “Agreement”) by and between DarkPulse, Inc., a Delaware corporation (the “Company”) and GHS Investments LLC, a Nevada limited liability company (“GHS”). The Company and GHS will be referred to individually as a “Party” and collectively as the “Parties.” Any capitalized terms not defined in this Amendment will have the meaning set forth in the Agreement, attached hereto as Exhibit A.
EQUITY FINANCING AGREEMENTEquity Financing Agreement • April 18th, 2023
This EQUITY FINANCING AGREEMENT (the “Agreement”), dated as of June 5, 2018 (the “Execution Date”), is entered into by and between Natural Health Farm Holdings, Inc., a Nevada corporation with its principal executive office at 1980 Festival Plaza Drive, Suite 530, Las Vegas, NV 89135 (the “Company”), and GHS Investments LLC, a Nevada limited liability company, with offices at 420 Jericho Turnpike, Suite 207, Jericho, NY 11753 (the “Investor”).
AMENDMENT NO. 3 TO THE STEP-UP EQUITY FINANCING AGREEMENT Dated as of December 15, 2006 CELL THERAPEUTICS, INC. SOCIÉTÉ GÉNÉRALEEquity Financing Agreement • December 21st, 2006 • Cell Therapeutics Inc • Pharmaceutical preparations
CELL THERAPEUTICS, INC. a Washington corporation with headquarters located at 501 Elliott Avenue, Suite 400, Seattle, Washington 98119, represented by James A. BIANCO, duly empowered,
MARIANO T. CUENCOEquity Financing Agreement • January 4th, 2019
corporation organized and existing under Presidential Decree No. 269, as amended, with office address at #57 NEA Building, NIA Road, Government Center, Diliman Quezon, City, hereinafter referred to as “NEA” represented herein by its Deputy Administrator, MARIANO T. CUENCO
EQUITY FINANCING AGREEMENTEquity Financing Agreement • February 9th, 2024 • DarkPulse, Inc. • Services-prepackaged software
This EQUITY FINANCING AGREEMENT (the “Agreement”), dated as of April 28, 2023 (the “Execution Date”), is entered into by and between DarkPulse, Inc., a Delaware corporation with its principal executive office at 815 Walker St., Suite 1155, Houston, Texas 77002 (the “Company”), and GHS Investments LLC, a Nevada limited liability company, with offices at 420 Jericho Turnpike, Suite 102, Jericho, NY 11753 (the “Investor”).
AMENDMENT NO. 2 TO THE STEP-UP EQUITY FINANCING AGREEMENT Dated as of September 30, 2006 CELL THERAPEUTICS, INC. SOCIÉTÉ GÉNÉRALEEquity Financing Agreement • October 5th, 2006 • Cell Therapeutics Inc • Pharmaceutical preparations
CELL THERAPEUTICS, INC. a Washington corporation with headquarters located at 501 Elliott Avenue, Suite 400, Seattle, Washington 98119, represented by James A. BIANCO, duly empowered,
AMENDMENT NO. 1 TO THE STEP-UP EQUITY FINANCING AGREEMENT Dated July 31, 2006 CELL THERAPEUTICS, INC. SOCIÉTÉ GÉNÉRALEEquity Financing Agreement • August 3rd, 2006 • Cell Therapeutics Inc • Pharmaceutical preparations
CELL THERAPEUTICS, INC. a Washington corporation with headquarters located at 501 Elliott Avenue, Suite 400, Seattle, Washington 98119, represented by James A. BIANCO, duly empowered,
EQUITY FINANCING AGREEMENTEquity Financing Agreement • February 19th, 2008 • Pantera Petroleum Inc. • Pharmaceutical preparations • Nevada
EQUITY FINANCING AGREEMENT (this "Agreement"), dated as of February 12, 2008, between PANTERA PETROLEUM INC., a Nevada corporation (the "Company"), and FTS FINANCIAL INVESTMENTS LTD., a corporation organized under the laws of Switzerland (the "Investor").
AMENDMENT No. 1 TO SECOND AMENDED EQUITY FINANCING AGREEMENTEquity Financing Agreement • February 9th, 2024 • DarkPulse, Inc. • Services-prepackaged software
This Amendment No. 1 to the Second Amended Equity Financing Agreement (this “Amendment”) dated January 30, 2024 is by and between DarkPulse, Inc., a Delaware corporation (the “Company”), on the one hand, and GHS Investments LLC, a Nevada limited liability company (the “GHS”), on the other hand. The Company and the GHS will be referred to individually as a “Party” and collectively as the “Parties.” Any capitalized terms not defined in this Amendment will have the meaning set forth in the Second Amended Equity Financing Agreement dated July 10, 2023, by and between the Company and GHS (the “Agreement”), attached hereto as Exhibit A.
AMENDMENT TO EQUITY FINANCING AGREEMENTEquity Financing Agreement • September 24th, 2018 • Financial Gravity Companies, Inc. • Finance services
THIS AMENDMENT TO EQUITY FINANCING AGREEMENT (the Amendment”) is entered into on September 4, 2018 and made effective as of May 23, 2017 by and between Financial Gravity Companies, Inc., a Nevada corporation (the “Company”) and GHS Investments, LLC, a Nevada limited liability company (the “Investor”). Each party to this Amendment is referred to herein as a “Party,” and collectively as the “Parties.”
RECITALS:Equity Financing Agreement • May 15th, 1998 • American International Petroleum Corp /Nv/ • Petroleum refining • New York
ContractEquity Financing Agreement • May 5th, 2020 • New York
EX-99.1 2 ex99-1.htm Exhibit 99.1 RESERVE EQUITY FINANCING AGREEMENT THIS AGREEMENT dated as of the 28 day of October, 2009 (the “Agreement”) between AGS Capital Group, LLC a New York limited liability corporation (the “Investor”), and INVO Bioscience, Inc., a corporation organized and existing under the laws of the State of Nevada (the “Company”). WHEREAS, the parties desire that, upon the terms and subject to the conditions contained herein, the Company shall issue and sell to the Investor, from time to time as provided herein, and the Investor shall purchase from the Company up to Ten Million Dollars ($10,000,000) of the Company’s common stock, par value $.0001 per share (the “Common Stock”), which shares of Common Stock shall be registered for resale pursuant to the Registration Rights Agreement (defined herein); and WHEREAS, such investments will be made in reliance upon the provisions of Regulation D (“Regulation D”) of the Securities Act of 1933, as amended, and the regulations
EQUITY FINANCING AGREEMENTEquity Financing Agreement • October 6th, 2010 • Mecox Lane LTD • New York
AGREEMENT entered by Mecox Lane Limited (the “Company”), a Cayman Islands company having its registered office at [P.O. Box 309GT, Ugland House, South Church Street, George Town, Grand Cayman, Cayman Islands], HiVentures Holdings Co., Ltd. (the “Optionee”), a British Virgin Island company having its registered office at [P.O.Box 3321, Road Town, Tortola, British Virgin Islands] and George Zhao (“Zhao”), a PRC citizen (ID No.: 11010819660330891) on this 16th day of June, 2008 and becomes effective on the same date.
